Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) in Single and Multiple Institutions: Limitations and Inferences

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 6, 2009, Pages 757-758

  Sorror, Mohamed L ^a,b   Storer, Barry ^a,b   Storb, Rainer F ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT SURVIVAL; HEMATOPOIETIC CELL TRANSPLANTATION SPECIFIC COMORBIDITY INDEX; HLA MATCHING; HUMAN; KIDNEY DISEASE; LETTER; LIVER DISEASE; LUNG DISEASE; METHODOLOGY; MORTALITY; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PROGNOSIS; SAMPLE SIZE; SCORING SYSTEM; SURVIVAL TIME; TREATMENT OUTCOME; VALIDATION STUDY;

COHORT STUDIES; COMORBIDITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MULTICENTER STUDIES AS TOPIC; PATIENTS; TREATMENT OUTCOME;

EID: 67349178457     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.02.007     Document Type: Letter

References (15)

1. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106 (2005) 2912-2919
2. Majhail N.S., Brunstein C.G., McAvoy S., et al. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants. Biol Blood Marrow Transplant 14 (2008) 985-992
3. Labonté L., Iqbal T., Zaidi M.A., et al. Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 14 (2008) 1039-1044
4. Sorror M.L., Giralt S., Sandmaier B.M., et al. Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 110 (2007) 4608-4613
5. Lim Z.Y., Ho A.Y., Ingram W., et al. Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes. Br J Haematol 135 (2006) 201-209
6. Maruyama D., Fukuda T., Kato R., et al. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen. Biol Blood Marrow Transplant 13 (2007) 932-941
7. Fujimaki K., Sakai R., Fujisawa S., et al. Usefulness of hematopoietic cell transplantation-specific comorbidity index after allogeneic hematopoietic stem cell transplantation [Japanese]. Gan to Kagaku Ryoho. [Jpn J Cancer Chemother 35 (2008) 87-91
8. Boehm A., Sperr W.R., Leitner G., et al. Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation. Eur J Clin Invest 38 (2008) 945-952
9. Barba P., Piñana J.L., Amoroso A., et al. Validation of comorbidity indexes in reduced-intensity conditioning (RIC) allogeneic stem cell transplantation. The Hematopoietic Cell Transplantation Comorbidity index is the best predictor of NRM and survival. Blood 112 (2008) 1125 [abstr. #3277]
10. Lim S.-N., Lee J.-H., Lee J.-H., et al. Pre-transplant comorbidity as an outcome predictor in hematopoietic cell transplantation for severe aplastic anemia. Blood (2008) 112 [abstr. #4295]
11. Mohty M., Labopin M., Cornelissen J.J., et al. Association between the haematopoietic cell transplantation-specific comorbidity index and non-relapse mortality after reduced-intensity conditioning allogeneic stem cell transplantation for AML in first complete remission: from the Acute Leukemia Working Party; European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2009) (in press)
12. Farina L, Bruno B, Patriarca F, et al. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation. Leukemia. [E-pub ahead of print 5 February 2009; doi: 10.1038/leu.2009.1].
13. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
14. Piccirillo J.F., Tierney R.M., Costas I., Grove L., and Spitznagel Jr. E.L. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291 (2004) 2441-2447
15. Kaplan M.H., and Feinstein A.R. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 27 (1974) 387-404